NASOPHARANGEAL CANCER
Clinical trials for NASOPHARANGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARANGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARANGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough cancers: drug tested across 25+ tumor types
Disease control Recruiting nowThis study is observing how well the drug T-DXd works for people with advanced HER2-positive cancers who have already tried other treatments and have no good options left. It will follow about 100 patients in real-world US clinics to see how their tumors respond and how long the …
Matched conditions: NASOPHARANGEAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Cancer trial questions need for immediate radiation
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer that has spread. It compares two approaches after initial drug therapy: getting radiation to the head and neck area right away versus waiting and only using radiation if the cancer comes back there. The main goal is to …
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer trial tests if boosting immune system beats standard chemo
Disease control Recruiting nowThis study compares two treatment approaches for people with high-risk nasopharyngeal cancer that has spread locally. One approach adds immunotherapy drugs to standard chemotherapy and radiation, while the other uses standard chemotherapy alone for maintenance. The goal is to see…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Timing test: does radiation after drugs help beat back returning cancer?
Disease control Recruiting nowThis study is for people whose nasopharyngeal cancer has returned after initial treatment. It tests whether adding radiation therapy immediately after a standard drug combination (immunotherapy plus chemotherapy) is better than waiting to see if it's needed later. The goal is to …
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC